Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2005-03-22
2005-03-22
Mosher, Mary E. (Department: 1648)
Chemistry: molecular biology and microbiology
Vector, per se
C435S325000, C435S069300, C536S023720
Reexamination Certificate
active
06869793
ABSTRACT:
Recombinant MVA viruses containing and/or capable of expressing dengue virus antigens and the use of such recombinant MVA for vaccination.
REFERENCES:
patent: 5185146 (1993-02-01), Altenburger
patent: 5369025 (1994-11-01), Nazerian et al.
patent: 5494671 (1996-02-01), Lai et al.
patent: 5514375 (1996-05-01), Paoletti et al.
patent: 5744141 (1998-04-01), Paoletti et al.
patent: 6074865 (2000-06-01), Kelly et al.
patent: 6440422 (2002-08-01), Sutter et al.
patent: WO 90 01946 (1990-03-01), None
patent: 9215672 (1992-09-01), None
patent: 9216636 (1992-10-01), None
Sutter et al (FEBS LETT. 371:9-12), 1995.*
Wyatt et al (Virology 210:202-5), 1995.*
Sutter et al (PNAS 89:10847-10851), 1992.*
Moss (Seminars in Immunology 2:317-327), 1990.*
Hayes et al (Pediatric infectious disease journal 11(4):311-7, abstract only cited), 1992.*
Bancroft.(Puerto Rico health sciences journal 6(11):23-6, abstract only cited), 1987.*
Monath et al. Flaviviruses. In: Fields Virology, third edition, ed. B. N. Fields et al. pp. 997-1004, 1996.*
Zhang et al. BBRC 200(1): 95-101, Apr. 1994.*
Selby et al (Journal of Virology 71: 7827-7831, Oct. 1997).*
Hirsch, V.M. et al., “Limited Virus Replication Following SIV Challenge of Macaques Immunized With Attenuated MVA Vaccinia Expressing SIVsm env and gag-pol”Vaccines 95 Modern Approaches to New Vaccines95:195-200 (1995).
Sutter, G. and Moss, B., “Novel Vaccinia Vector Derived From the Host Range Restricted and Highly Attenuated MVA Strain of Vaccinia Virus”Developments in Biological Standardization84:195-200 (1995).
Yamshchikov, V.F. et al., “Generation of Long Flavivirus Expression Cassettes by in vivo Recombination and Transient Dominant Selection”Gene149:193-201 (1994).
Cardosa Mary Jane
Erfle Volker
Sutter Gerd
Bavarian Nordic Research Institute
Bingham & McCutchen LLP
Konski Antoinette F.
Mosher Mary E.
LandOfFree
Recombinant MVA virus expressing dengue virus antigens, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant MVA virus expressing dengue virus antigens, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant MVA virus expressing dengue virus antigens, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3384203